Novel 5-methylcytosine Oxidases

Information

  • Research Project
  • 8453553
  • ApplicationId
    8453553
  • Core Project Number
    R44GM105132
  • Full Project Number
    1R44GM105132-01
  • Serial Number
    105132
  • FOA Number
    PA-12-088
  • Sub Project Id
  • Project Start Date
    9/1/2013 - 10 years ago
  • Project End Date
    2/28/2014 - 10 years ago
  • Program Officer Name
    MAAS, STEFAN
  • Budget Start Date
    9/1/2013 - 10 years ago
  • Budget End Date
    2/28/2014 - 10 years ago
  • Fiscal Year
    2013
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/26/2013 - 10 years ago

Novel 5-methylcytosine Oxidases

DESCRIPTION: With the recent discovery of 5-hydroxymethylcytosine in mammalian DNA and the TET enzyme family responsible for its generation, it is clear that the mammalian DNA epigenome is much more complex than had been thought. A lot of questions remain to be answered about the in vivo roles and the in vitro properties of the TET enzymes. In this fast-track application, we propose studying the TET-like enzymes in the single-cell protist Naegleria gruberi. They are much smaller in size than the human TET enzymes and are much easier to produce and engineer. A panel of biochemical assays will be carried out to thoroughly characterize the in vitro properties of the active TET-like enzymes in N. gruberi. We aim at providing these enzymes as reagents to the research market. Since 5-methylcytosine (5mC) is an important epigenetic marker in mammalian genomic DNA, these enzymes should enable many creative experiments, e.g., direct sequencing of the epigenome, because they functionalize the chemically inert 5mC. To enhance their versatility, we propose using enzyme engineering to look for mutants with altered or improved properties. For this purpose, we will determine the 3D structure of at least one active TET-like enzymes. We plan to apply the wild-type enzymes or derived mutants in several epigenomic applications and determine the methylome/hydroxymethylome changes during the differentiation process of N. gruberi, which may shed lights on the similar processes in the more complex biological systems. In summary, our studies will bring a number of novel enzymatic reagents to the research market and generate scientific insights on epigenetic regulation involving 5hmC.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    251006
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:251006\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NEW ENGLAND BIOLABS, INC.
  • Organization Department
  • Organization DUNS
    066605403
  • Organization City
    IPSWICH
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    019382723
  • Organization District
    UNITED STATES